1.The Imaginary Desensitization in the Static State of Qigong
Xueyu LV ; Menghan LV ; Weidong WANG
International Journal of Traditional Chinese Medicine 2009;31(6):540-541
The article aims to introduce a creative desensitization therapy to enrich modem clinic psychological treatment. The imaginary desensitization in the static state of Qigong is one method of the systemic Chinese medicine psychological treatments (SPT). It is suitable for the Chinese cultural background and the psychological characteristics of Chinese people.
2.Assumptions on Building TCM Psychological Crisis Intervention Theory Conforming to Chinese Situation
Xueyu LV ; Weidong WANG ; Yongdong HU ; Lan HONG ; Yanjiao LIU ; Menghan LV
International Journal of Traditional Chinese Medicine 2008;30(6):461-462
Objective To explore the construction of TCM psychological crisis interventional theoretical system.Methods Based on the experience of TCM psychological medical group participated in the crisis intervention therapy after the earthquake,we draw a theoretical conclusion and made arrangement from the perspective of the disciplinary development of TCM psychology.Result We developed some assumptions to build the TCM psychological crisis intervention theory which conformed to the Chinese situation.Conclusion The building of crisis intervention theory must conform to Chinese situation and Can be applicable to lead the practice.The theory in this article should be enriched and improved in practice later.
3.The characteristics of rapid eye movement sleep of depressed patients and its correlation with severity degree of depression
Xueyu LV ; Yanjiao LIU ; Weidong WANG ; Meng JING ; Yingna LIN ; Fang WANG
Chinese Journal of Behavioral Medicine and Brain Science 2011;20(5):418-420
Objective To explore the characteristics of polysomnography (PSG) of depressed patients and the correlation between rapid eye movement (REM) and severity degree of depression. Methods Polysomnography was used to assess patients'sleep condition and Montgomery-Asberg depression scale (MADRS) was used to assess the severity degree of depression. 90 patients and 30 healthy controls were included. Results Compared to healthy controls,sleep progress of depressed patients changed as follow:prolonged sleep latency((25.2 ±15.25) minutes) ,lowered sleep efficiency(0.853 ±0.11) ;the architecture of sleep also changed:percentage of stage 1 increased( (27.7 ± 16.38) % ),percentage of REM sleep increased( (22. 8 ± 6. 1 ) % ) , percentage of stage 2 decreased ((40.2±11.3)%), percentage of slow wave sleep decreased ((11.8 ±9. 32)%); REM sleep significantly changed; decreased REM latency((79. 27 ±30. 44) minutes) , increased REM activity((129. 0 ±53. 12) u) .increased intensity of REM((36.7 ±14.0)u/min), increased REM density((159.2 ±57.2)u/min) were observed in depressed patients. There was no obvious correlation between the variance of REM and severity degree of depression. Conclusion There are a series of changes in sleep progress, architecture and REM sleep of depression and the change of REM sleep can be specified to diagnose depression. However,there is no causality between REM variance and severity of depression.
4.Preparation of PEI-RGD/~(125)I-(α_v)ASODN and its inhibitory effect on invasive ability of HepG2 cells
Haidong CAI ; Yu QIAO ; Xueyu YUAN ; Yuehua YANG ; Shidong YUAN ; Ming SUN ; Zhongwei LV
Chinese Journal of Cancer Biotherapy 2009;16(6):609-613
Objective:To study the effects of ~(125)I-(α_v)ASODN on the in vitro invasive ability of heptocellular carcino-ma cell line(HepG2) through PEI-RGD-mediated receptor process. Methods: Intergrin α_v-specific antisense oligonucle-otide was labeled with ~(125)I, and PEI-RGD/~(125)I-(α_v)ASODN complex was prepared by combining ~(125)I-(α_v)ASODN with polyethyleneimine derivative PEI-RGD. PEI-RGD/~(125)I-(α_v)ASODN complex was transferred into HepG2 cells through the receptor-mediated process. The effect of PEI-RGD/~(125)I-(α_v)ASODN complex on the invasive ability of HepG2 cells was examined by Boyden chamber invasive assay. Results: (1) The labeling yield and radiochemical purity of ~(125)I-(α_v) ASODN were(73.78±4.09)% and(96.68±1.38)%, respectively, and the labeled compound had a good stability in vitro after 48 h at 37℃; (2) The ability of HepG2 cells to uptake PEI-RGD/~(125)I-(α_v)ASODN reached its peek ([12.77±0.85] % ) when PEI-RGD/~(125)I-(α_v)ASODN was at 4 μl/2 μg ([12.77±0.85] %), and then gredually decreased thereafter. So the dosage of PEI-RGD/~(125)I-(α_v)ASODN for the following experiment was chosen as 2 μl/1 μg; (3) The invasive capacity of HepG2 cells was significantly reduced in PEI-RGD/~(125)I-(α_v)ASODN group compared with those in other experiment and control groups (P <0.01 ). Conclusion: ~(125)I-(α_v)ASODN mediated by PEI-RGD can effectively inhibit the invasive capacity of HepG2 cells.